Welcome to the Journal
International Journal of Clinical Rheumatology is at the cutting edge of the most recent clinical, translational and lab based exploration to propel the treatment for a wide range of rheumatic diseases and disorders which includes themes, for example, treatment, surgery, imaging and clinical education.
The journal is committed to distribute most elevated quality studies identified with clinical determination and administration of rheumatic ailments through facilitated parts of clinical consideration and clinical examination concentrated on propelling treatment and personal satisfaction for individuals with joint pain, immune system infections, bone issue and related conditions. This journal offers an open access platform to Rheumatology community where, the authors can publish all the reliable sources of information on research findings and current developments as original articles, reviews, case studies, clinical images, short communications, commentaries, etc. and all the published materials will be accessed online all over the world without any subscription fee. The journal gives fundamental perusing to rheumatologists and additionally orthopedic specialists, pharmacologists, pathologists, radiologists, general experts and other wellbeing experts with an enthusiasm for patients with rheumatic maladies.
The journal also incorporates original papers inside the assorted fields of rheumatology, clinical experimentation as well as medicine, pathologic process, immunology, immunopathology, microbiology, clinical problems involving joints, soft tissues, auto-immune diseases, heritable connective tissue disorders and different types of radiological studies.
Fast Editorial Execution and Review Process (FEE-Review Process):
International Journal of Clinical Rheumatology is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Indexing: Scimago, Excerpta Medica (EMBASE), CAS (Chemical Abstracts Service), SHERPA RoMEO, CNKI, Open J Gate
Submit your manuscripts through Online Manuscript Submission System
Contact Editorial Office at [email protected]
Articles published in International Journal of Clinical Rheumatology have been cited by esteemed scholars and scientists all around the world. International Journal of Clinical Rheumatology has got h-index 32 , which means every article in International Journal of Clinical Rheumatology has got 32 average citations.
Recently Published Articles
Perspective p. 155-156
Choice of Contraception May Influence Rheumatoid Arthritis Autoimmunity Risk
Author(s): Silvano Adami
Opinion Article p. 157-158
Symptoms of 'Chronic Multisymptom Illness' May be Common in Iraq, Afghanistan Vets
Author(s): Rene Westhovens
Commentary p. 159-160
Mummy Remains Refute Antiquity of Ankylosing Spondylitis
Author(s): Ronald A Asherson
Perspective p. 161-162
Herpes Zoster Vaccine Safe for Use in Rheumatoid Arthritis Patients on Biologics
Author(s): TJ Martin